Rubicon Research IPO Allotment, Listing Live Updates: Rubicon Research's unlisted shares are trading at ₹628, reflecting a grey market premium (GMP) of 29.48% over the upper price band of ₹485.

Rubicon Research IPO Allotment, Listing Live Updates: The company had set a price range of ₹461 to ₹485 per share.

Rubicon Research IPO Listing Live Updates: Here's a look at Rubicon Research's financial performance.

Rubicon Research IPO Listing Date Live Updates: If you have missed checking allotment details, here's are direct links to track status.

• MUFG Intime India: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
• BSE: https://bseindia.com/investors/appli_check.aspx
• NSE: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

Rubicon Research IPO Allotment Live Updates: Shares will be credited to the Demat account of successful investors on Wednesday, October 15. Refunds for unsuccessful investors will also be processed on the same day.

Rubicon Research IPO Allotment Live Updates: Investors who have applied for the Rubicon Research IPO can check their allotment status through the following links:

• MUFG Intime India: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
• NSE: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• BSE: https://bseindia.com/investors/appli_check.aspx

Rubicon Research IPO Allotment Live Updates: Shares of Rubicon Research Limited will hit secondary market - the BSE and the NSE - on Thursday, October 16.

Rubicon Research IPO Allotment Live Updates: Rubicon Research is a pharmaceutical formulation company with a strong focus on R&D as well as innovation. Its portfolio includes an increasing number of speciality products and drug-device combination products targeting regulated markets, particularly the United States.

The firm has also been expanding its manufacturing footprint. In June, it acquired Alkem Laboratories' formulations facility in Madhya Pradesh's Pithampur, in an all-cash deal worth ₹149 crore.

It currently operates two US FDA-inspected R&D facilities- one in India and another in Canada- along with two manufacturing plants in India accredited by multiple regulatory authorities, including USFDA, Maharashtra FDA (WHO-GMP), and Health Canada.

Rubicon Research IPO Allotment Live Updates: Investors who have applied for the Rubicon Research IPO can visit the following links to track the allotment status.

• MUFG Intime India: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
• NSE: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
• BSE: https://bseindia.com/investors/appli_check.aspx

Rubicon Research IPO Allotment Live Updates: A lot consisted of 30 shares and in multiples thereafter.

Rubicon Research IPO Allotment Live Updates: Shares will be credited to the Demat account of successful investors on Wednesday, October 15. Refunds for unsuccessful investors will also be processed on the same day.

Rubicon Research IPO Allotment Live Updates: The company had set a price band of ₹461 to ₹485 per share.

Rubicon Research IPO Allotment Live Updates: The unlisted shares of Rubicon Research Ltd, according to media reports and investorgain.com, are trading at ₹605, reflecting a grey market premium of 264.74%, or ₹120, over the upper price band of ₹485.

Rubicon Research IPO Allotment Live Updates: If you have applied for Rubicon Research's IPO, here are the steps you can follow to check allotment status on MUFG Intime India.

• Visit this link: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
• Select 'Rubicon Research Ltd' from the list of IPOs
• Identify yourself using Account No/IFSC, Application No, DP/Client ID or PAN
• Click on 'Submit'

Rubicon Research IPO Allotment Live Updates: The allotment details are expected to out on portals of registrar, MUFG Intime India, the NSE and the BSE by late evening.